Lack of group-to-individual generalizability in people with lower urinary tract symptoms emphasizes the need for deep phenotyping and personalized treatments Journal of Clinical and Translational Science 1 August 2025;9(1)
Date
08/01/2025DOI
10.1017/cts.2025.10113Scopus ID
2-s2.0-105012773239 (requires institutional sign-in at Scopus site)Author List
Andreev VP, Smerdon C, Bieber B, Smith AR, Flynn K, Clemens JQ, Cella D, Yang CC, Kirkali Z, Weinfurt K, Amundsen C, Jelovsek JE, Hokanson J, Lentz A, Page D, Siddiqui N, Harshbarger T, Odom M, Gridley C, Foreman J, Morgan T, Guerrero M, Yu S, Sinha A, Bradley CS, Kreder K, Erickson BA, Fick D, Magnotta V, Polgreen P, Hollenbeck N, Bretschneider CE, Griffith JW, Kenton K, Helfand B, Geynisman-Tan J, Glaser A, Mueller M, Farina F, Fantus R, Boehm D, Marquez M, Antoniak M, Talaty P, John K, Shi J, Samsel T, DeLancey J, Fenner D, Harris R, Harte S, Cameron AP, Sarma A, Ippolito G, Gupta P, Horner W, Thompson J, Schmidt P, Mowatt G, Richardson S, Mathai S, Mubeenah S, Kirby A, Levendovszky SR, Gutta S, Vicars B, Covert H, Lai HH, Shimony J, Li F, Hayden P, Klim A, Graff J, Gillespie B, Durkin J, Sexton M, Nashif J, Goodrich N, Andrews C, Lu T, Remski C, Mullins CAuthors
Kathryn Eve Flynn PhD Vice Chair, Professor in the Medicine department at Medical College of WisconsinJames A. Hokanson PhD Assistant Professor in the Biomedical Engineering department at Medical College of Wisconsin
